You are here
- Home
- Total number of clinical trials
A Phase I, Open-label, Single-center Study to Assess the Pharmacokinetics of a Single Oral Dose of VIMOVO (250 mg Naproxen/20 mg Esomeprazole)in Healthy Adult Subjects
- Drug Name
- Vimovo
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- I
- Start Date
- May 24, 2011
- Study Name
- D1120C00040
- Study Id
- D1120C00040
- ClinicalTrials.gov ID
- NCT01358383
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Oct 27, 2011
- D1120C00040.pdf (174 KB)
